Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.163B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 950,000 | $280M | 12.9% | $54.23 | +243.4% | COM NEW | 74006W207 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $224M | 10.4% | $11.58 | — | COM NEW | 107924102 |
| ABVX | ABIVAX SA | 1,350,000 | $182M | 8.4% | $10.70 | — | SPONSORED ADS | 00370M103 |
| QQQ | INVESCO QQQ TR | 250,000 | $154M | 7.1% | — | — | Put | 46090E103 |
| EYPT | EYEPOINT INC | 8,265,000 | $151M | 7.0% | $11.03 | +28.4% | COM NEW | 30233G209 |
| IWM | ISHARES TR | 500,000 | $123M | 5.7% | — | — | Put | 464287655 |
| XBI | SPDR SERIES TRUST | 1,000,000 | $122M | 5.6% | — | — | Put | 78464A870 |
| RAPP | RAPPORT THERAPEUTICS INC | 3,027,521 | $91.85M | 4.2% | $22.73 | +21.7% | COM | 75383L102 |
| BBIO | BRIDGEBIO PHARMA INC | 1,200,000 | $91.79M | 4.2% | $20.96 | +213.2% | COM | 10806X102 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 1,059,331 | $82.67M | 3.8% | $35.19 | +89.9% | COM NEW | 10919W405 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,285,000 | $81.52M | 3.8% | $23.73 | -15.4% | COM | 28036F105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,750,000 | $68.75M | 3.2% | $17.79 | 0.0% | COM | 68062P106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4,355,433 | $57.4M | 2.7% | $11.99 | -1.6% | CLASS A ORD | 61559X104 |
| INSM | INSMED INC | 275,000 | $47.86M | 2.2% | $37.15 | +391.2% | COM PAR $.01 | 457669307 |
| ENGN | ENGENE HOLDINGS INC | 4,000,000 | $36.12M | 1.7% | $8.99 | -10.8% | COM | 29286M105 |
| ALMS | ALUMIS INC | 3,635,596 | $35.48M | 1.6% | $10.71 | -34.8% | COM | 022307102 |
| MBX | MBX BIOSCIENCES INC | 1,120,000 | $35.32M | 1.6% | $18.80 | +29.1% | COM | 55287L101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,000,000 | $35.08M | 1.6% | $20.31 | +79.2% | ORDINARY SHARES | N62509109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,325,000 | $33.14M | 1.5% | $13.13 | — | SPONSORED ADS | 152309100 |
| PHVS | PHARVARIS N V | 1,083,000 | $30.05M | 1.4% | $21.48 | +12.1% | COM | N69605108 |
| BIOA | BIOAGE LABS INC | 2,040,605 | $27M | 1.2% | $18.97 | -53.3% | COM | 09077V100 |
| ASND | ASCENDIS PHARMA A/S | 100,000 | $21.32M | 1.0% | $213.24 | — | SPONSORED ADR | 04351P101 |
| TARS | TARSUS PHARMACEUTICALS INC | 250,000 | $20.47M | 0.9% | $21.36 | +249.5% | COM | 87650L103 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,344,971 | $19.09M | 0.9% | $28.57 | -56.8% | COM NEW | 21833P301 |
| GHRS | GH RESEARCH PLC | 1,300,000 | $16.51M | 0.8% | $13.91 | -2.1% | ORDINARY SHARES | G3855L106 |
| ORKA | ORUKA THERAPEUTICS INC | 533,340 | $16.17M | 0.7% | $14.82 | +88.0% | COM | 687604108 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 500,000 | $14.52M | 0.7% | $7.71 | +231.9% | COM | 03969K108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 300,000 | $13.96M | 0.6% | $24.75 | +79.8% | COM | 22663K107 |
| AXSM | AXSOME THERAPEUTICS INC | 75,000 | $13.7M | 0.6% | $74.04 | +88.6% | COM | 05464T104 |
| CABA | CABALETTA BIO INC | 4,400,000 | $9.636M | 0.4% | $1.56 | +58.9% | COM | 12674W109 |
| JANX | JANUX THERAPEUTICS INC | 650,000 | $8.97M | 0.4% | $40.93 | -42.5% | COM | 47103J105 |
| COGT | COGENT BIOSCIENCES INC | 225,000 | $7.992M | 0.4% | $28.11 | 0.0% | COM | 19240Q201 |
| PCVX | VAXCYTE INC | 125,000 | $5.768M | 0.3% | $53.56 | -16.5% | COM | 92243G108 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 400,000 | $4.832M | 0.2% | $9.41 | +44.3% | COM | 03237H101 |
| BHVN | BIOHAVEN LTD | 10,000 | $113K | 0.0% | $43.60 | -71.6% | COM | G1110E107 |